This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore criteria to identify altcoins safe for long-term holding, including fundamentals, liquidity, and community support. Start evaluating with confidence.
27,729 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Bitcoin trades near a critical threshold as Grayscale signals potential value on-chain. This report weighs whether bi...
A high-growth, small-cap name has tumbled after a rough period. This guide breaks down whether the dip creates a real...
As Kevin Warsh opens his first Federal Reserve meeting, AMD sits near all-time highs. Analysts and traders weighing e...
Nvidia unveiled a large stake in Iren to support a 5GW global AI factory plan, sending Iren’s stock higher even as th...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
AMD is grabbing attention as its stock soars. This guide breaks down the core drivers, the risks, and concrete steps ...
Ethereum slid again as it tests a crucial resistance area, with any short-term recovery fading beneath the larger dow...
Palantir delivers a strong Q1, beating expectations with better profitability than many software peers, yet the stock...
OpenAI will stagger the rollout of its top AI model, requiring government clearance for initial access. The move coul...
As AI chips grab headlines, investors wonder if will cerebras soar after its IPO. While history offers clues, the pat...
The investing landscape is shifting as tech layoffs continue, big acquisitions reshape markets, and SpaceX pivots tow...